Annual / Quarterly Financial Statement • Apr 9, 2025
Annual / Quarterly Financial Statement
Open in ViewerOpens in native device viewer
REPORT AND FINANCIAL STATEMENTS 31 December 2024
| CONTENTS | PAGE |
|---|---|
| PAGE | ||
|---|---|---|
| Board of Directors and other officers | 1 |
|---|---|
| Board of Directors report | 2 - 4 |
| Independent auditor's report | 5 - 8 |
| Statement of profit or loss and other comprehensive income | 9 |
| Statement of financial position | 10 |
| Statement of changes in equity | 11 |
| Statement of cash flows | 12 |
| Notes to the financial statements | 13 - 29 |
| Board of Directors: | Nayia Morphi - Executive member Maria Demetriou - Non-executive member Zoe Christou Tziortzi - Non-executive member |
|---|---|
| Company Secretary: | Omniserve Ltd 17-19 Themistokli Dervi Street The City House 1066, Nicosia Cyprus |
| Independent Auditors: | Baker Tilly Klitou and Partners Ltd Certified Public Accountants and Registered Auditors Corner C Hatzopoulou & 30 Griva Digheni Avenue 1066, Nicosia Cyprus |
| Legal Advisers: | Ioannides Demetriou LLC 17-19 Themistokli Dervi Street The City House 1066, Nicosia Cyprus |
| Registered office: | 33 Vasilissis Freiderikis Palais D'Ivoire, Floor 2 1066, Nicosia Cyprus |
| Bankers: | Astrobank Limited 1, Spyrou Kyprianou Avenue 1065, Nicosia Cyprus |
| Piraeus Bank (Greece) S.A. 4 Amerikis street 105 64 Athens Greece |
|
| Registration number: | HE420422 |
The Board of Directors presents its report and audited financial statements of Phoenix Vega Mezz Plc (the "Company") for the year ended 31 December 2024.
The Company Phoenix Vega Mezz Plc was incorporated in Cyprus on 12 April 2021 as a private limited liability company under the provisions of the Cyprus Companies Law, Cap. 113.
On 21 July 2021, the Company was renamed from Phoenix Vega Mezz Ltd to Phoenix Vega Mezz PLC and was transformed to a public limited liability company under the provisions of the Cyprus Companies Law.
On 12 August 2021, the shares of the Company were listed in the Alternative Market EN.A. Plus of the Athens Stock Exchange.
The principal activity of the Company, which remains unchanged from last year, is the holding and management of the following notes (the "Νotes"):
On the issuance of the Notes, a Priority of Payments Schedule ("Waterfall'') was established, which is settled on a quarterly basis. Based on this schedule, the principal repayments regarding the mezzanine and junior notes are the last ones in the order of priority. The Waterfall is as follows:
The contractual documents of the securitizations stipulate that after 24 months from the entry into force of the HAPS, if at the date of payment of interest on the mezzanine notes, the total net collections from the beginning of the portfolio servicing is falling short by 15% or more from the budgeted net collections, as specified in the respective business plan, the payment of the total (100%) of the interest payable at the relevant date to the holders of the mezzanine notes is deferred.
The deferred interest is payable on the first interest payment date of the mezzanine notes at which, either the Senior notes' principal has been repaid in full, or the balance between actual and budgeted net collections has been fully restored, subject to funds being available for the payment of the interest of the mezzanine notes, otherwise on the following determined date for the payment of interest on the mezzanine notes.
In the aforementioned context, the payment of coupons to the holders of the mezzanine notes issued by Vega III NPL Finance DAC has been deferred for all quarters of 2024, while since Q2 of 2024, the payment of coupons to the holders of the mezzanine notes issued by Phoenix NPL Finance DAC has been also deferred. The deferred interest payments will be restored once the respective conditions referred to in the previous paragraph are met.
Cumulatively within 2024, the Company received coupon payments of €10,604,297 in relation to the Notes it holds (2023: €20,015,443).
Following the update of the business plans of the securitized portfolios, the fair value of financial assets measured at fair value through profit or loss increased in the current period, primarily attributable to the revision of the estimated future cash flows of the Notes.
The Company's development to date, financial results, and position as presented in the financial statements are considered satisfactory.
The principal risks and uncertainties faced by the Company are disclosed in notes 6 and 7 of the financial statements.
The Company is exposed to market risk, interest rate risk, credit risk and liquidity risk from the financial instruments it holds.
Market risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in market prices and that such changes will affect The Company's income or the value of its holdings of financial instruments.
Interest rate risk is the risk that the value of financial instruments will fluctuate due to changes in market interest rates. Interest bearing assets issued at variable rates expose the Company to cash flow interest rate risk. Interest bearing assets issued at fixed rates exposes the Company to fair value interest rate risk. The Company's Management monitors the interest rate fluctuations on a continuous basis and acts accordingly.
Credit risk is the risk that one party to a financial instrument will cause a financial loss for the other party by failing to meet an obligation. Credit risk arises from debt instruments and deposits with banks and financial institutions.
Liquidity risk is the risk that arises when the maturity of assets and liabilities does not match. An unmatched position potentially enhances profitability, but can also increase the risk of losses. The Company has established procedures with objective of minimizing such losses and maintaining sufficient cash and other highly liquid current assets.
The Company's results for the year are set out on page 9. The net profit for the year attributable to the shareholders of the Company amounted to €59,600,851 (2023: €11,192,752). On 31 December 2024 the total assets of the Company were €91,415,326 (2023: €47,685,359) and the net assets of the Company were €91,181,689 (2023: €47,585,538).
Upon incorporation on 12 April 2021 the Company issued to the subscribers of its Memorandum of Association 2,000 ordinary shares of €1 each at par.
On 28 April 2021, the Company increased its share capital to 26,431,868 ordinary shares of €1 each at nominal value.
Based on shareholders' decision, on 25 May 2021 the share capital was converted into 528,637,360 ordinary shares of nominal value of €0.05 each, and increased to 1,250,367,229 ordinary shares of €0.05 each at nominal value.
On the same date, 1,250,367,229 shares of nominal value of €0.05 each were subscribed to Piraeus Financial Holdings SA for €0.05 i.e. total value €62,518,361 in exchange for the contribution of the Notes at a fair value of €62,516,361 based on the valuation of independent valuers.
On 13 July 2022, during the course of the Company's Annual General Meeting ("AGM"), the shareholders approved the proposal of the Board of Directors to reduce the nominal value of each ordinary share by €0.0144 from €0.05 to €0.0356 each. The amount of share capital decrease was distributed to the Company's shareholders in cash.
On 29 September 2022, the share capital reduction was approved via court order. The Company's issued share capital was reduced to €44,513,073 divided into 1,250,367,229 ordinary shares of €0.0356 each.
On 12 July 2023, during the course of the Company's AGM the shareholders approved the proposal of the Board of Directors to reduce the nominal value of each ordinary share by €0.0144 from €0.0356 to €0.0212 each. The amount of share capital decrease was distributed to the Company's shareholders in cash.
On 16 October 2023, the share capital reduction was approved via court order. The Company's issued share capital was reduced to €26,507,785 divided into 1,250,367,229 ordinary shares of €0.0212 each.
On 5 July 2024, during the course of the Company's AGM the shareholders approved the proposal of the Board of Directors to reduce the nominal value of each ordinary share by €0.0128 from €0.0212 to €0.0084 each. The amount of share capital decrease was distributed to the Company's shareholders in cash.
On 24 October 2024, the share capital reduction was approved via court order. The Company's issued share capital was reduced to €10,503,085 divided into 1,250,367,229 ordinary shares of €0.0084 each.
The members of the Company's Board of Directors as at 31 December 2024 and at the date of this report are presented on page 1.
All of them were members of the Board of Directors throughout the year ended 31 December 2024.
In accordance with the Company's Articles of Association all Directors presently members of the Board continue in office.
There were no significant changes in the assignment of responsibilities and remuneration of the Board of Directors.
During February 2025, the company received coupon payments of €3,367,170.
The independent Auditors of the Company, Baker Tilly Klitou & Partners Limited have expressed their willingness to continue in office and a resolution giving authority to the Board of Directors to fix their remuneration will be proposed at the AGM.
By order of the Board of Directors,
Omniserve Ltd Secretary
9 April 2025

Corner C. Hatzopoulou & 30 Griva Digheni Avenue 1066, Nicosia P.O Box 27783, 2433 Nicosia Cyprus
T: +357 22 458500 F: +357 22 751648
[email protected] www.bakertilly.com.cy
We have audited the financial statements of Phoenix Vega Mezz Plc (the ''Company''), which are presented in pages 9 to 29 and comprise the statement of financial position as at 31 December 2024, and the statements of comprehensive income, changes in equity and cash flows for the year then ended, and notes of the financial statements, including material accounting policy information.
In our opinion, the accompanying financial statements give a true and fair view of the financial position of the Company as at 31 December 2024, and of its financial performance and its cash flows for the year then ended in accordance with International Financial Reporting Standards (IFRSs) as adopted by the European Union and the requirements of the Cyprus Companies Law, Cap. 113.
We conducted our audit in accordance with International Standards on Auditing (ISAs). Our responsibilities under those standards are further described in the ''Auditor's Responsibilities for the Audit of the Financial Statements'' section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountants' International Code of Ethics for Professional Accountants (including International Independence Standards) (IESBA Code) together with the ethical requirements that are relevant to our audit of the financial statements in Cyprus, and we have fulfilled our other ethical responsibilities in accordance with these requirements and the IESBA Code. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
Key audit matters are those matters that, in our professional judgment, were of most significance in our audit of the financial statements of the current period. These matters were addressed in the context of our audit of the financial statements as a whole, and in forming our opinion thereon, and we do not provide a separate opinion on these matters.
ADVISORY ASSURANCE TAX
Baker Tilly Klitou & Partners Ltd trading as Baker Tilly is a member of the global network of Baker Tilly International Ltd., the members of which are separate and independent legal entities.

The carrying value of the Company's investments at fair value through profit or loss ("FVTPL") as at 31 December 2024 amounted to 72,517,831 which represents 79.33% of the total assets of the Company. The total investments in the financial assets excluding those classified at amortised cost at the statement of financial position date, were initially recognized at fair value of 26,528,091 at January 2024.
The Company's management determines the fair value of its investments at FVTPL, with the assistance of external independent valuators.
The size of the said investments, the significance of estimates and judgments as well as the subjectivity of the valuation process warrant specific audit focus and therefore represents a key audit matter.
Refer to notes 5, 6.5, 7, and 14 of the financial statements for the accounting estimates and judgments used in the determination of the fair value and further details in relation to the said investments
Based on the risk assessment and following a risk-based approach, we performed, among others, the following audit procedures:
With the support of our internal valuation specialists we (i) assessed the relevance and appropriateness of the evaluation methodologies applied, (ii) challenged the appropriateness of the key assumptions including discount rates and expected future cash flows, (iii) evaluated the appropriateness of the other market transactions concerning the same instrument considered by the external independent valuers, and (v) checked the mathematical accuracy of the calculations made in the valuation workings.
We assessed the completeness and accuracy of the related disclosures in the notes to the financial statements in accordance with the relevant accounting standards (IFRSs).
The Board of Directors is responsible for the other information. The other information comprises the information included in the Management Report, but does not include the financial statements and our auditor's report thereon.
Our opinion on the financial statements does not cover the other information and we do not express any form of assurance conclusion thereon.
In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard.
The Board of Directors is responsible for the preparation of financial statements that give a true and fair view in accordance with International Financial Reporting Standards as adopted by the European Union and the requirements of the Cyprus Companies Law, Cap. 113 and for such internal control as the Board of Directors determines is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.
In preparing the financial statements, the Board of Directors is responsible for assessing the Company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the Board of Directors either intends to liquidate the Company or to cease operations, or has no realistic alternative but to do so.
ADVISORY ASSURANCE TAX
Baker Tilly Klitou & Partners Ltd trading as Baker Tilly is a member of the global network of Baker Tilly International Ltd., the members of which are separate and independent legal entities.

The Board of Directors is responsible for overseeing the Company's financial reporting process.
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.
As part of an audit in accordance with ISAs, we exercise professional judgment and maintain professional scepticism throughout the audit. We also:
We communicate with the Board of Directors regarding, among other matters, the planned scope and timing of the audit and significant audit findings, including any significant deficiencies in internal control that we identify during our audit.
Pursuant to the additional requirements of the Auditors Law of 2017, we report the following:
ADVISORY ASSURANCE TAX
Baker Tilly Klitou & Partners Ltd trading as Baker Tilly is a member of the global network of Baker Tilly International Ltd., the members of which are separate and independent legal entities.

This report, including the opinion, has been prepared for and only for the Company's members as a body in accordance with Section 69 of the Auditors Law of 2017 and for no other purpose. We do not, in giving this opinion, accept or assume responsibility for any other purpose or to any other person to whose knowledge this report may come to.
Moisis Aristidou Certified Public Accountant and Registered Auditor for and on behalf of
Baker Tilly Klitou and Partners Ltd Corner C Hatzopoulou & 30 Griva Digheni Avenue 1066 Nicosia Cyprus
Nicosia, 9 April 2025
ADVISORY ASSURANCE TAX
Baker Tilly Klitou & Partners Ltd trading as Baker Tilly is a member of the global network of Baker Tilly International Ltd., the members of which are separate and independent legal entities.
| Note | 01/01/2024- 31/12/2024 € |
01/01/2023- 31/12/2023 € |
|
|---|---|---|---|
| Interest income Net gains/(losses) from financial assets at fair value through profit or loss Net gains/(losses) from adjustments on investments at amortised cost |
8 14 13 |
9,258,196 49,053,468 2,723,432 |
9,871,928 3,202,847 - |
| Total net income | 61,035,096 | 13,074,775 | |
| Impairment losses on investments at amortised costs Administration and other expenses Operating profit |
13 9 |
(433,504) (380,156) 60,221,436 |
(691,756) (343,617) 12,039,402 |
| Finance income Finance costs |
469,389 (1,387) |
282,112 (2,641) |
|
| Net finance income/(costs) | 10 | 468,002 | 279,471 |
| Profit before tax | 60,689,438 | 12,318,873 | |
| Tax | 11 | (1,088,587) | (1,126,121) |
| Net profit for the year | 59,600,851 | 11,192,752 | |
| Other comprehensive income | - | - | |
| Total comprehensive income for the year | 59,600,851 | 11,192,752 | |
| Profit per share attributable to equity holders (cent) | 12 | 4.77 | 0.90 |
The notes on pages 13 to 29 form an integral part of these financial statements.
31 December 2024
| 31/12/2024 | 31/12/2023 | ||
|---|---|---|---|
| ASSETS | Note | € | € |
| Non-current assets | |||
| Investments at amortised cost Financial assets at fair value through profit or loss |
13 14 |
10,402,551 72,517,831 |
6,394,996 26,528,091 |
| 82,920,382 | 32,923,087 | ||
| Current assets | |||
| Receivables Refundable taxes Cash and cash equivalents |
18 15 |
11,244 266,440 8,217,260 |
33,768 364,646 14,363,858 |
| 8,494,944 | 14,762,272 | ||
| Total assets | 91,415,326 | 47,685,359 | |
| EQUITY AND LIABILITIES | |||
| Equity | |||
| Share capital Retained earnings |
16 | 10,503,085 80,678,604 |
26,507,785 21,077,753 |
| Total equity | 91,181,689 | 47,585,538 | |
| Current liabilities | |||
| Trade and other payables Current tax liabilities |
17 18 |
99,379 134,258 |
99,821 - |
| Total liabilities | 233,637 | 99,821 | |
| Total equity and liabilities | 91,415,326 | 47,685,359 |
On 9 April 2025 the Board of Directors of Phoenix Vega Mezz Plc authorised these financial statements for issue.
Director Director
Maria Demetriou Zoe Christou Tziortzi
The notes on pages 13 to 29 form an integral part of these financial statements.
31 December 2024
| Note | Share capital € |
Retained earnings € |
Total € |
|
|---|---|---|---|---|
| Opening balance as at 1 January 2023 Net profit for the year Reduction of share capital |
44,513,073 - (18,005,288) |
9,884,996 11,192,752 - |
54,398,069 11,192,752 (18,005,288) |
|
| Balance as at 1 January 2024 | 26,507,785 | 21,077,753 | 47,585,538 | |
| Net profit for the year Reduction of share capital |
16 | - (16,004,700) |
59,600,851 - |
59,600,851 (16,004,700) |
| Balance as at 31 December 2024 | 10,503,085 | 80,678,604 | 91,181,689 |
Companies, which do not distribute 70% of their profits after tax, as defined by the Special Contribution for the Defence of the Republic Law, within two years after the end of the relevant tax year, will be deemed to have distributed this amount as dividend on the 31 of December of the second year. The amount of the deemed dividend distribution is reduced by any actual dividend already distributed by 31 December of the second year for the year the profits relate. The Company pays special defence contribution on behalf of the shareholders over the amount of the deemed dividend distribution at a rate of 17% (applicable since 2014) when the entitled shareholders are individual tax residents of Cyprus and have their domicile in Cyprus. In addition, the Company pays on behalf of the shareholders General Healthcare System (GHS) contribution at a rate of 2.65%, when the entitled shareholders are individual tax residents of Cyprus, regardless of their domicile.
The notes on pages 13 to 29 form an integral part of these financial statements.
| 01/01/2024- 31/12/2024 |
01/01/2023- 31/12/2023 |
||
|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | Note | € | € |
| Profit before tax Adjustments for: |
60,689,438 | 12,318,873 | |
| Net (gains)/losses from financial assets at fair value through profit or loss Net (gains)/losses from adjustments on investments at amortised cost |
14 13 |
(49,053,468) (2,723,432) |
(3,202,847) - |
| Impairment losses on investments at amortised cost Finance income |
13 10 |
433,504 (469,389) |
691,756 (282,112) |
| Interest income from financial assets at fair value through profit or loss Interest income from financial assets at amortised cost |
8 8 |
(7,540,569) (1,717,627) |
(8,396,175) (1,475,753) |
| (381,543) | (346,258) | ||
| Changes in working capital: | |||
| Decrease in receivables (Decrease)/increase in trade and other payables |
22,524 (442) |
379,629 5,521 |
|
| Coupons received | 10,604,297 | 20,015,453 | |
| Cash generated from operations before income tax payments | 10,244,836 | 20,054,345 | |
| Tax paid | (856,123) | (1,117,906) | |
| Net cash generated from operating activities | 9,388,713 | 18,936,439 | |
| CASH FLOWS FROM INVESTING ACTIVITIES | |||
| Interest received | 469,389 | 282,112 | |
| Net cash generated from investing activities | 469,389 | 282,112 | |
| CASH FLOWS FROM FINANCING ACTIVITIES | |||
| Distributions from return of share capital | (16,004,700) | (18,005,288) | |
| Net cash used in financing activities | (16,004,700) | (18,005,288) | |
| Net (decrease)/increase in cash and cash equivalents | (6,146,598) | 1,213,263 | |
| Cash and cash equivalents at beginning of the year | 14,363,858 | 13,150,595 | |
| Cash and cash equivalents at end of the year | 15 | 8,217,260 | 14,363,858 |
The notes on pages 13 to 29 form an integral part of these financial statements.
The Company Phoenix Vega Mezz Plc (the ''Company'') was incorporated in Cyprus on 12 April 2021 as a private limited liability company under the provisions of the Cyprus Companies Law, Cap. 113. On 2 July 2021 it was transformed into a public limited liability company and on 12 August 2021 its shares were listed in the Alternative Market EN.A. of the Athens Stock Exchange.
Its registered office is at 33 Vasilissis Freiderikis, Palais D'Ivoire, Floor 2, 1066, Nicosia, Cyprus.
The principal activity of the Company, which remains unchanged from last year, is the holding and management of the following notes (the "Νotes"):
The annual financial statements of the Company have been prepared in accordance with International Financial Reporting Standards (IFRSs) as adopted by the European Union (EU) and the requirements of the Cyprus Companies Law, Cap. 113. The financial statements have been prepared under the historical cost convention and financial assets at fair value through profit or loss.
The preparation of financial statements in conformity with IFRSs requires the use of certain critical accounting estimates and requires Management to exercise its judgment in the process of applying the Company's accounting policies. It also requires the use of assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Although these estimates are based on Management's best knowledge of current events and actions, actual results may ultimately differ from those estimates. The areas involving a higher degree of judgment or complexity, or areas where assumptions and estimates are significant to the financial statements are disclosed in Note 7.
The financial statements are presented in Euro (€) which is the functional currency of the Company.
During the current year the Company adopted all the new and revised International Financial Reporting Standards (IFRS) that are relevant to its operations and are effective for accounting periods beginning on 1 January 2024.
The principal accounting policies adopted in the preparation of these financial statements are set out below. These policies have been consistently applied to all years presented in these financial statements unless otherwise stated.
The financial statements of the Company have been prepared on a going concern basis.
Interest income from the Notes is recognised on a time proportion by using the effective interest method. Effective interest rate is the rate that exactly discounts estimated future cash payments or receipt through the expected life of the financial asset to gross carrying amount of a financial asset. Interest income is classified under "Interest income" line in the statement of profit or loss and other comprehensive income. For purchased or originated credit impaired financial assets, interest income is calculated by applying the credit- adjusted effective interest rate to the amortised cost of the asset.
Interest expense is charged to profit or loss as incurred.
Income tax expense represents the sum of the tax currently payable and deferred tax.
Current tax liabilities and assets are measured at the amount expected to be paid to or recovered from the taxation authorities, using the tax rates and laws that have been enacted, or substantively enacted, by the reporting date.
Deferred tax is provided in full, using the liability method, on temporary differences arising between the tax bases of assets and liabilities and their carrying amounts in the financial statements. Currently enacted tax rates are used in the determination of deferred tax.
Deferred tax assets are recognised to the extent that it is probable that future taxable profit will be available against which the temporary differences can be utilised.
Deferred tax assets and liabilities are offset when there is a legally enforceable right to set off current tax assets against current tax liabilities and when the deferred taxes relate to the same fiscal authority.
The Company classifies its financial assets in the following measurement categories:
The classification and subsequent measurement of debt financial assets depends on: (i) the Company's business model for managing the related assets portfolio and (ii) the cash flow characteristics of the asset. On initial recognition, the Company may irrevocably designate a debt financial asset that otherwise meets the requirements to be measured at amortised cost or at fair value through other comprehensive income ("FVOCI") or at FVTPL if doing so eliminates or significantly reduces an accounting mismatch that would otherwise arise.
Investments in mezzanine (Class B2) notes issued by Vega III were classified at amortised cost at initial recognition (refer to note 13).
All other financial assets are classified as measured at FVTPL (refer to note 14).
For assets measured at fair value, gains and losses will be recorded in profit or loss.
All purchases and sales of financial assets that require delivery within the time frame established by regulation or market convention (''regular way'' purchases and sales) are recorded at trade date, which is the date when the Company commits to deliver a financial instrument. All other purchases and sales are recognised when the entity becomes a party to the contractual provisions of the instrument.
Financial assets are derecognised when the rights to receive cash flows from the financial assets have expired or have been transferred and the Company has transferred substantially all the risks and rewards of ownership.
At initial recognition, the Company measures a financial asset at its fair value plus, in the case of a financial asset not at fair value through profit or loss (FVTPL), transaction costs that are directly attributable to the acquisition of the financial asset. Transaction costs of financial assets carried at FVTPL are expensed in profit or loss. Fair value at initial recognition is best evidenced by the transaction price. A gain or loss on initial recognition is only recorded if there is a difference between fair value and transaction price which can be evidenced by other observable current market transactions in the same instrument or by a valuation technique whose inputs include only data from observable markets.
Subsequent measurement of debt instruments depends on the Company's business model for managing the asset and the cash flow characteristics of the asset. There are three measurement categories into which the Company classifies its debt instruments:
Amortised cost: Assets that are held for collection of contractual cash flows where those cash flows represent solely payments of principal and interest are measured at amortised cost. Interest income from these financial assets is included in 'Interest Income'. Any gain or loss arising on derecognition is recognised directly in profit or loss and presented in other gains/(losses) together with foreign exchange gains and losses. Impairment losses are presented as separate line item in the statement of profit or loss and other comprehensive income. Financial assets measured at amortised cost (AC) comprise: cash and cash equivalents, trade receivables and investments at amortised cost.
FVOCI: Assets that are held for collection of contractual cash flows and for selling the financial assets, where the assets' cash flows represent solely payments of principal and interest, are measured at FVOCI. Movements in the carrying amount are recognised through OCI, except for the recognition of impairment gains or losses, interest income and foreign exchange gains and losses which are recognised in profit or loss. When the financial asset is derecognised, the cumulative gain or loss previously recognised in OCI is reclassified from equity to profit or loss and recognised in other gains/(losses). Interest income from these financial assets is included in 'Interest income''. Foreign exchange gains and losses are presented in ''other gains/(losses)'' and impairment expenses are presented as separate line item in the statement of profit or loss and other comprehensive income.
FVTPL: Assets that do not meet the criteria for amortised cost or FVOCI are measured at FVTPL. A gain or loss on financial assets that are subsequently measured at FVTPL is recognised in profit or loss and presented net within ''gains/(losses) from financial assets at FVTPL'' in the period in which it arises.
The Company assesses on a forward-looking basis the ECL for investments measured at amortised cost. The Company measures ECL and recognises credit loss allowance at each reporting date. The measurement of ECL reflects: (i) an unbiased and probability weighted amount that is determined by evaluating a range of possible outcomes, (ii) time value of money and (iii) all reasonable and supportable information that is available without undue cost and effort at the end of each reporting period about past events, current conditions and forecasts of future conditions.
The carrying amount of the financial assets is reduced through the use of an allowance account, and the amount of the loss is recognised in the statement of profit or loss and other comprehensive income within '' Impairment losses on investments at amortised costs". Subsequent recoveries of amounts for which loss allowance was previously recognised are credited against the same line item.
The impairment methodology applied by the Company for calculating expected credit losses depends on the type of financial asset assessed for impairment. Specifically:
For trade receivables and contract assets, including trade receivables and contract assets with a significant financing component, and lease receivables the Company applies the simplified approach permitted by IFRS 9, which requires lifetime expected credit losses to be recognised from initial recognition of the financial assets.
For all other financial instruments that are subject to impairment under IFRS 9, the Company applies general approach - three stage model for impairment. The Company applies a three stage model for impairment, based on changes in credit quality since initial recognition. A financial instrument that is not credit-impaired on initial recognition is classified in Stage 1.
Financial assets in Stage 1 have their ECL measured at an amount equal to the portion of lifetime ECL that results from default events possible within the next 12 months or until contractual maturity, if shorter (''12 Months ECL''). If the Company identifies a significant increase in credit risk (''SICR'') since initial recognition, the asset is transferred to Stage 2 and its ECL is measured based on ECL on a lifetime basis, that is, up until contractual maturity but considering expected prepayments, if any (''Lifetime ECL''). Refer to note 6, Credit risk section, for a description of how the Company determines when a SICR has occurred. If the Company determines that a financial asset is creditimpaired, the asset is transferred to Stage 3 and its ECL is measured as a Lifetime ECL. The Company's definition of credit impaired assets and definition of default is explained in note 6, Credit risk section.
Additionally, the Company has decided to use the low credit risk assessment exemption for investment grade financial assets. Refer to note 6, Credit risk section for a description of how the Company determines low credit risk financial assets.
Financial instruments are reclassified only when the business model for managing those assets changes. The reclassification has a prospective effect and takes place from the start of the first reporting period following the change.
Financial assets are written-off, in whole or in part, when the Company exhausted all practical recovery efforts and has concluded that there is no reasonable expectation of recovery. The write-off represents a derecognition event. The Company may write-off financial assets that are still subject to enforcement activity when the Company seeks to recover amounts that are contractually due, however, there is no reasonable expectation of recovery.
The Company sometimes renegotiates or otherwise modifies the contractual terms of the financial assets. The Company assesses whether the modification of contractual cash flows is substantial considering, among other, the following factors: any new contractual terms that substantially affect the risk profile of the asset (e.g. profit share or equity-based return), significant change in interest rate, change in the currency denomination, new collateral or credit enhancement that significantly affects the credit risk associated with the asset or a significant extension of a loan when the borrower is not in financial difficulties.
If the modified terms are substantially different, the rights to cash flows from the original asset expire and the Company derecognises the original financial asset and recognises a new asset at its fair value. The date of renegotiation is considered to be the date of initial recognition for subsequent impairment calculation purposes, including determining whether a SICR has occurred. The Company also assesses whether the new loan or debt instrument meets the SPPI criterion. Any difference between the carrying amount of the original asset derecognised and fair value of the new substantially modified asset is recognised in profit or loss, unless the substance of the difference is attributed to a capital transaction with owners.
In a situation where renegotiations result to modifications in the terms of the financial asset and the terms of the modified asset are not substantially different from those of the original asset, the Company recalculates the gross carrying amount by discounting the modified contractual cash flows with the original effective interest rate, and recognises a modification gain or loss in profit or loss.
For the purpose of the statement of cash flows, cash and cash equivalents comprise cash at bank. Cash and cash equivalents are carried at amortised cost because: (i) they are held for collection of contractual cash flows and those cash flows represent SPPI, and (ii) they are not designated at FVTPL.
Financial liabilities are initially recognised at fair value and classified as subsequently measured at amortised cost, except for (i) financial liabilities at FVTPL: this classification is applied to derivatives, financial liabilities held for trading (e.g. short positions in securities), contingent consideration recognised by an acquirer in a business combination and other financial liabilities designated as such at initial recognition and (ii) financial guarantee contracts and loan commitments.
A financial liability is derecognised when the obligation under the liability is discharged or cancelled or expires.
Trade payables are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Trade and other payable are classified as current liabilities if payment is due within one year or less (or in the normal operating cycle of the business if longer). If not, they are presented as non-current liabilities. Trade and other payables are recognised initially at fair value and subsequently measured at amortised cost using the effective interest method.
An exchange between the Company and its original lenders of debt instruments with substantially different terms, as well as substantial modifications of the terms and conditions of existing financial liabilities, are accounted for as an extinguishment of the original financial liability and the recognition of a new financial liability. The terms are substantially different if the discounted present value of the cash flows under the new terms, including any fees paid net of any fees received and discounted using the original effective interest rate, is at least 10% different from the discounted present value of the remaining cash flows of the original financial liability. (In addition, other qualitative factors, such as the currency that the instrument is denominated in, changes in the type of interest rate, new conversion features attached to the instrument and change in loan covenants are also considered.)
If an exchange of debt instruments or modification of terms is accounted for as an extinguishment, any costs or fees incurred are recognised as part of the gain or loss on the extinguishment. If the exchange or modification is not accounted for as an extinguishment, any costs or fees incurred adjust the carrying amount of the liability and are amortised over the remaining term of the modified liability.
Modifications of liabilities that do not result in extinguishment are accounted for as a change in estimate using a cumulative catch up method, with any gain or loss recognised in profit or loss, unless the economic substance of the difference in carrying values is attributed to a capital transaction with owners and is recognised directly to equity.
Ordinary shares are classified as equity.
Provisions are recognised when the Company has a present legal or constructive obligation as a result of past events, it is probable that an outflow of resources will be required to settle the obligation, and a reliable estimate of the amount can be made. Where the Company expects a provision to be reimbursed, for example under an insurance contract, the reimbursement is recognised as a separate asset but only when the reimbursement is virtually certain.
The Company is exposed to interest rate risk, credit risk, liquidity risk and capital risk management arising from the financial instruments it holds. The risk management policies employed by the Company to manage these risks are discussed below:
Interest rate risk is the risk that the value of financial instruments will fluctuate due to changes in market interest rates.
At the reporting date the interest rate profile of interest- bearing financial instruments was:
| 31/12/2024 | 31/12/2023 | |
|---|---|---|
| Fixed rate instruments | € | € |
| Class (B2) Mezzanine | 82,920,382 | 32,923,087 |
| Cash at bank | 8,217,260 | 14,363,858 |
| 91,137,642 | 47,286,945 |
Credit risk is the risk that one party to a financial instrument will cause a financial loss for the other party by failing to meet an obligation. Credit risk arises from cash and cash equivalents and contractual cash flows from the Notes.
Credit risk is managed on an individual basis. For banks and financial institutions, the Company has established policies whereby the majority of bank balances are held with independently rated parties with a minimum rating of ['C'].
The Company has the following types of financial assets that are subject to the expected credit loss model:
6.2 Credit risk (continued)
Impairment losses are presented as net impairment losses on financial and contract assets within operating profit. Subsequent recoveries of amounts previously written off are credited against the same line item.
The Company has decided to use the low credit risk assessment exemption for investment grade financial assets. Management considers 'low credit risk' for listed bonds to be an investment grade credit rating with at least one major rating agency. Other instruments are considered to be low credit risk when they have a low risk of default and the issuer has a strong capacity to meet its contractual cash flow obligations in the near term.
The Company's exposure to credit risk for each class of (asset/instrument) subject to the expected credit loss model is set out below:
The Company assesses, on an individual basis, its exposure to credit risk arising from cash at bank. This assessment takes into account, ratings from external credit rating institutions and internal ratings, if external are not available.
Bank deposits held with banks with investment grade rating, are considered as low credit risk.
The gross carrying amounts below represent the Company's maximum exposure to credit risk on these assets as at 31 December 2024 and 31 December 2023:
| Company internal credit rating | External credit rating | 31/12/2024 | 31/12/2023 |
|---|---|---|---|
| Performing | BBB - B | € 8,217,260 |
€ 14,363,858 |
| Total | 8,217,260 | 14,363,858 |
The Company does not hold any collateral as security for any cash at bank balances.
There were no cash at bank balances written off during the year that are subject to enforcement activity.
(iii) Net impairment losses on financial assets recognised in profit or loss
During the year, the following ECL allowance for impairment losses were recognised in profit or loss in relation to investments measured at amortised cost measure:
| Impairment losses | 01/01/2024- | 01/01/2023- |
|---|---|---|
| 31/12/2024 | 31/12/2023 | |
| € | € | |
| Impairment charge - Investments at amortised cost | (433,504) | (691,756) |
| Net impairment loss on financial and contract assets | (433,504) | (691,756) |
Liquidity risk is the risk that arises when the maturity of assets and liabilities does not match. An unmatched position potentially enhances profitability, but can also increase the risk of losses. The Company has procedures with the objective to minimise such losses, such as maintaining sufficient cash and other highly liquid current assets and by having available an adequate amount of committed credit facilities.
6.3 Liquidity risk (continued)
The following tables detail the Company's remaining contractual maturity for its financial liabilities. The tables have been drawn up based on the undiscounted cash flows of financial liabilities based on the earliest date on which the Company can be required to pay. The table includes both interest and principal cash flows.
| 31 December 2024 | Carrying | Contractual | |
|---|---|---|---|
| amounts | cash flows | 1-2 years | |
| € | € | € | |
| Trade and other payables | 29,892 | 29,892 | 29,892 |
| Shareholders' credit balance | 3,526 | 3,526 | 3,526 |
| VAT | 6,461 | 6,461 | 6,461 |
| Accruals | 59,500 | 59,500 | 59,500 |
| 99,379 | 99,379 | 99,379 | |
| 31 December 2023 | Carrying | Contractual | |
| amounts | cash flows | 1-2 years | |
| € | € | € | |
| Trade and other payables | 46,123 | 46,123 | 46,123 |
| Shareholders' credit balance | 2,035 | 2,035 | 2,035 |
| VAT | 1,167 | 1,167 | 1,167 |
| Accruals | 50,496 | 50,496 | 50,496 |
| 99,821 | 99,821 | 99,821 |
Capital includes equity shares, loan from parent company and payables to related parties.
The Company's objectives in managing capital are to safeguard the Company's ability to continue as a going concern in order to provide returns for shareholders and to maintain an optimal capital structure to reduce the cost of capital.
In order to maintain or adjust the capital structure, the Company may adjust the amount of dividends paid to shareholders, any return of capital to shareholders or the issuing of new shares.
The Company monitors capital on the basis of the gearing ratio. This ratio is calculated as net debt divided by total capital. Net debt is calculated as total borrowings. Total capital is calculated as ''equity'' as shown in the statement of financial position plus net debt.
The Company did not have any borrowings as at 31 December 2024.
The table below depicts the carrying amounts and fair values of certain financial assets and liabilities, which are either material or their carrying amount is not a reasonable approximation of fair value:
| Carrying amounts | Fair values | |||
|---|---|---|---|---|
| 31/12/2024 | 31/12/2023 | 31/12/2024 | 31/12/2023 | |
| € | € | € | € | |
| Financial assets | ||||
| Cash and cash equivalents | 8,217,260 | 14,363,858 | 8,217,260 | 14,363,858 |
| Fair value through profit or loss | 72,517,831 | 26,528,091 | 72,517,831 | 26,528,091 |
| Amortised cost | 10,402,551 | 6,394,996 | 15,622,958 | 6,542,313 |
| Financial liabilities | ||||
| Trade payables | (99,379) | (99,825) | (99,379) | (99,825) |
| 91,038,263 | 47,187,120 | 96,258,670 | 47,334,437 |
The fair value of financial instruments that are not traded in an active market is determined by using valuation techniques. The Company considers a variety of valuation methods and makes assumptions that are based on market conditions existing at the reporting date.
The increase in the fair value of financial assets measured at fair value through profit or loss in the current year, is primarily attributable to the revision of the estimated future cash flows of the notes, following the update in the business plans of the securitized portfolios, and lower discount rates applied.
The table below analyses financial instruments carried at fair value, by valuation method. The different levels have been defined as follows:
| 31 December 2024 | Level 1 € |
Level 2 € |
Level 3 € |
Total € |
|---|---|---|---|---|
| Financial assets at fair value through profit or loss |
||||
| Mezzanine notes (Class B2) | - | - | 72,517,831 | 72,517,831 |
| 31 December 2023 | Level 1 € |
Level 2 € |
Level 3 € |
Total € |
| Financial assets Mezzanine notes (Class B2) |
- | - | 26,528,091 | 26,528,091 |
The fair value reconciliation of Level 3 financial instruments is depicted in Note 14 "Financial assets at fair value through profit or loss". The changes in the fair value of financial instruments are recognized in the statement of profit or loss and other comprehensive income, under line item "Net gains/(losses) from financial assets at fair value through profit or loss".
The fair value of Junior notes (Class C2) is nil.
The Company utilizes an income approach valuation technique. Specifically, the Company determines the fair value of the Notes by discounting future cash flows utilizing revised business plan estimates adjusted for actual recovery rates to date and an additional haircut applied throughout the second half of the residual term assumed. A build up approach is followed on the discount rate determination utilizing observable market data (i.e. risk-free rates) and various unobservable data (i.e. risk premia) to replicate market participants perspective towards the Notes.
The following table presents the valuation techniques used to measure the fair values of Level 3 financial instruments in the statement of financial position, along with the significant unobservable inputs applied:
| Financial instruments |
Valuation technique |
Significant unobservable inputs |
Range 2024 |
Range 2023 |
||
|---|---|---|---|---|---|---|
| Low | High | Low | High | |||
| Financial assets at fair value through profit or loss |
Discounted Expected Cash Flows method (DCF) |
Discount Rate | 15.67% | 15.67% | 19.8% | 19.8% |
| Residual term assumed |
10 yrs | 10 yrs | 2.5 yrs | 2.5 yrs | ||
| Haircut applied | 40% | 40% | n/a | n/a |
The following table presents the effect in the statement of profit or loss and other comprehensive income of reasonable possible changes in one of the significant unobservable inputs of Level 3 financial instruments as of the reporting date, keeping all other inputs constant.
| Main assumptions | Change in the assumptions |
Statement of profit or loss and total equity | ||
|---|---|---|---|---|
| Favourable changes | Unfavourable changes | |||
| Discount rate | +/-1% | 2,252,154 | (2,118,314) | |
| Residual term assumed | +/- 1 year | 5,949,626 | (7,471,409) | |
| Haircut applied | +/-5% | 1,554,865 | (1,554,865) |
Estimates and judgments are continually evaluated and are based on historical experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances.
The Company makes estimates and assumptions concerning the future. The resulting accounting estimates will, by definition, seldom equal the related actual results. The estimates and assumptions that have a significant risk of causing a material adjustment to the carrying amounts of assets and liabilities within the next financial year are discussed below.
When measuring expected credit losses the Company uses reasonable and supportable forward looking information, which is based on assumptions for the future movement of different economic drivers and how these drivers will affect each other.
Loss given default is an estimate of the loss arising on default. It is based on the difference between the contractual cash flows due and those that the lender would expect to receive, taking into account cash flows from collateral and integral credit enhancements.
Probability of default constitutes a key input in measuring ECL. Probability of default is an estimate of the likelihood of default over a given time horizon, the calculation of which includes historical data, assumptions and expectations of future conditions.
Significant judgment is required in determining the provision for income taxes. There are transactions and calculations for which the ultimate tax determination is uncertain during the ordinary course of business. The Company recognises liabilities for anticipated tax audit issues based on estimates of whether additional taxes will be due. Where the final tax outcome of these matters is different from the amounts that were initially recorded, such differences will impact the income tax and deferred tax provisions in the period in which such determination is made.
Critical judgements in applying the Company's accounting policies
The fair value of financial instruments that are not traded in an active market is determined by using valuation techniques. The Company uses its judgment to select a variety of methods and make assumptions that are mainly based on market conditions existing at each reporting date. The fair value of the financial assets at FVTPL has been estimated based on discounted expected cash flows valuation model and various inputs as analysed in 6.5.
The loss allowances for financial assets are based on assumptions about risk of default and expected loss rates. The Company uses judgement in making these assumptions and selecting the inputs to the impairment calculation, based on the Company's past history, existing market conditions as well as forward looking estimates at the end of each reporting period. Details of the key assumptions and inputs used are disclosed in note 6, Credit risk section.
Interest income is analysed as follows:
| 01/01/2024- 31/12/2024 € |
01/01/2023- 31/12/2023 € |
|
|---|---|---|
| Interest income from financial assets at fair value through profit or loss | 7,540,569 | 8,396,175 |
| Interest income from financial assets at amortised cost | 1,717,627 | 1,475,753 |
| Total interest income | 9,258,196 | 9,871,928 |
Interest income is recognised using the effective interest rate method.
| 01/01/2024- | 01/01/2023- | |
|---|---|---|
| 31/12/2024 | 31/12/2023 | |
| € | € | |
| Annual levy | - | 350 |
| Insurance | 30,502 | 31,502 |
| Audit fees | 29,000 | 30,000 |
| Accounting fees | 19,500 | 18,704 |
| Legal fees | 18,014 | 20,900 |
| Directors' fees | 24,000 | 24,000 |
| Other professional fees | 205,289 | 171,549 |
| Unrecoverable VAT | 53,851 | 46,612 |
| 380,156 | 343,617 |
| 01/01/2024- | 01/01/2023- | |
|---|---|---|
| 31/12/2024 | 31/12/2023 | |
| € | € | |
| Interest income | 469,389 | 282,112 |
| Finance income | 469,389 | 282,112 |
| Bank charges | (1,387) | (2,641) |
| Finance costs | (1,387) | (2,641) |
| Net finance income | 468,002 | 279,471 |
Interest income is generated by Company's deposits accounts.
| 01/01/2024- 31/12/2024 |
01/01/2023- 31/12/2023 |
|
|---|---|---|
| € | € | |
| Corporation tax - current year | 914,258 | 738,123 |
| Corporation tax - prior years | 174,329 | 371,998 |
| Overseas tax | - | 16,000 |
| Charge for the year | 1,088,587 | 1,126,121 |
The tax on the Company's profit before tax differs from theoretical amount that would arise using the applicable tax rates as follows:
| 01/01/2024- | 01/01/2023- | |
|---|---|---|
| 31/12/2024 | 31/12/2023 | |
| € | € | |
| Profit before tax | 60,689,438 | 12,318,873 |
| Tax calculated at the applicable tax rates | 7,586,180 | 1,539,859 |
| Tax effect of allowances and income not subject to tax | (6,671,922) | (801,736) |
| Prior year tax | 174,329 | 371,998 |
| Overseas tax in excess of credit claim used during the year | - | 16,000 |
| Tax charge | 1,088,587 | 1,126,121 |
The corporation tax rate is 12.5%.
Under certain conditions interest income may be subject to defence contribution at the rate of 17%. In such cases this interest will be exempt from corporation tax. In certain cases, dividends received from abroad may be subject to defence contribution at the rate of 17%.
Gains on disposal of qualifying titles (including shares, bonds, debentures, rights thereon etc.) are exempt from Cyprus income tax.
| 01/01/2024- 31/12/2024 |
01/01/2023- 31/12/2023 |
|
|---|---|---|
| Profit attributable to shareholders (€) | 59,600,851 | 11,192,752 |
| Weighted average number of ordinary shares in issue during the year | 1,250,367,229 | 1,250,367,229 |
| Profit per share attributable to equity holders (cent) | 4.77 | 0.90 |
Movement in gross carrying amount of investments at amortised cost.
| 2024 | 2023 | |
|---|---|---|
| € | € | |
| Balance as at 1 January | 7,086,752 | 7,886,187 |
| Other adjustments | 2,723,432 | - |
| Interest income | 1,717,627 | 1,475,753 |
| Coupons received | - | (2,275,188) |
| Gross balance as at 31 December | 11,527,811 | 7,086,752 |
| Cumulative impairment losses | (1,125,260) | (691,756) |
| Net balance as at 31 December | 10,402,551 | 6,394,996 |
Based on the existing contractual governance framework of the securitizations, decisions on significant financial and operating matters of the Issuers require the unanimous consent of the Class B1 and B2 noteholders. On this basis, the Issuers are jointly controlled by the said noteholders, meeting the joint venture definition. No investment in joint ventures has been recognised, as the Company does not hold any equity interest in the Issuers, thus its proportionate share of their net assets is zero. The Company does not hold any interests in the Issuers, other than the Class B2 and Class C2 notes, which are accounted for under IFRS 9.
During 2024, the interest to the holders of the mezzanine notes issued by Vega III NPL Finance DAC was deferred.
As at 31 December 2024 an additional ECL charge was recognized on Vega III financial asset amounting to €433,504 (31 December 2023: €691,756). The cumulative ECL stood at €1,125,260. Following a revision on the estimated cash flows of Vega III financial asset, the Company proceeded with an upward adjustment in the amortized cost of the note by €2,723,432 which recognized in the statement of profit and loss.
| 2024 | 2023 | |
|---|---|---|
| € | € | |
| Balance as at 1 January | 26,528,091 | 32,669,332 |
| Interest income | 7,540,569 | 8,396,175 |
| Change in fair value | 49,053,468 | 3,202,847 |
| Coupons received | (10,604,297) | (17,740,263) |
| Balance as at 31 December | 72,517,831 | 26,528,091 |
The fair value of junior notes (Class C2) is estimated to nil.
Cash balances are analysed as follows:
| 31/12/2024 | 31/12/2023 | |
|---|---|---|
| € | € | |
| Cash at bank | 8,217,260 | 14,363,858 |
| 8,217,260 | 14,363,858 |
The exposure of the Company to credit risk and impairment losses in relation to cash and cash equivalents is reported in note 6 of the financial statements.
| 2024 Number of |
2024 | 2023 Number of |
2023 | |
|---|---|---|---|---|
| shares | € | shares | € | |
| Authorised | ||||
| Ordinary shares | 1,250,367,229 | 26,507,785 | 1,250,367,229 | 44,513,073 |
| Reduction of nominal value of Share Capital | - | (16,004,700) | - | (18,005,288) |
| 1,250,367,229 | 10,503,085 | 1,250,367,229 | 26,507,785 | |
| Issued and fully paid | ||||
| Balance as at 1 January | 1,250,367,229 | 26,507,785 | 1,250,367,229 | 44,513,073 |
| Reduction of nominal value of Share Capital | - | (16,004,700) | - | (18,005,288) |
| Balance as at 31 December | 1,250,367,229 | 10,503,085 | 1,250,367,229 | 26,507,785 |
Upon incorporation on 12 April 2021 the Company issued to the subscribers of its Memorandum of Association 2,000 ordinary shares of €1 each at par.
On 28 April 2021, the share capital was increased to 26,431,868 ordinary shares of nominal value of €1 each, equal to €26,431,868.
Based on shareholders' decision, on 25 May 2021 the share capital was converted into 528,637,360 ordinary shares of nominal value of €0.05 each, and increased to 1,250,367,229 ordinary shares of €0.05 each at nominal value.
On 13 July 2022, during the course of the Company's AGM, the shareholders approved the proposal of Board of Directors to reduce the nominal value of each ordinary share by €0.0144 from €0.05 to €0.0356 each. The amount of share capital decrease was distributed to the Company's shareholders in cash.
On 29 September 2022, the share capital reduction was approved via court order. The Company's issued share capital was reduced to €44,513,073 divided in 1,250,367,229 ordinary shares of €0.0356 each.
On 12 July 2023, during the course of the Company's AGM the shareholders approved the proposal of Board of Directors to reduce the nominal value of each ordinary share by €0.0144 from €0.0356 to €0.0212 each. The amount of share capital decrease was distributed to the Company's shareholders in cash.
On 16 October 2023, the share capital reduction was approved via court order. The Company's issued share capital was reduced to €26,507,785 divided in 1,250,367,229 ordinary shares of €0.0212 each.
On 5 July 2024, during the course of the Company's AGM the shareholders approved the proposal of Board of Directors to reduce the nominal value of each ordinary share by €0.0128 from €0.0212 to €0.0084 each. The amount of share capital decrease was distributed to the Company's shareholders in cash.
On 24 October 2024, the share capital reduction was approved via court order. The Company's issued share capital was reduced to €10,503,085 divided in 1,250,367,229 ordinary shares of €0.0084 each.
Upon incorporation on 12 April 2021 the Company issued to the subscribers of its Memorandum of Association 2,000 ordinary shares of €1 each at par.
On 28 April 2021, the Company increased its share capital to 26,431,868 ordinary shares of €1 each at nominal value.
Based on shareholders' decision, on 25 May 2021 the share capital was converted into 528,637,360 ordinary shares of nominal value of €0.05 each, and increased to 1,250,367,229 ordinary shares of €0.05 each at nominal value.
On 13 July 2022, during the course of the Company's AGM, the shareholders approved the proposal of Board of Directors to reduce the nominal value of each ordinary share by €0.0144 from €0.05 to €0.0356 each. The amount of share capital decrease was distributed to the Company's shareholders in cash.
On 29 September 2022, the share capital reduction was approved via court order. The Company's issued share capital was reduced to €44,513,073 divided in 1,250,367,229 ordinary shares of €0.0356 each.
On 12 July 2023, during the course of the Company's AGM the shareholders approved the proposal of Board of Directors to reduce the nominal value of each ordinary share by €0.0144 from €0.0356 to €0.0212 each. The amount of share capital decrease was distributed to the Company's shareholders in cash.
On 16 October 2023, the share capital reduction was approved via court order. The Company's issued share capital was reduced to €26,507,785 divided in 1,250,367,229 ordinary shares of €0.0212 each.
On 5 July 2024, during the course of the Company's AGM the shareholders approved the proposal of Board of Directors to reduce the nominal value of each ordinary share by €0.0128 from €0.0212 to €0.0084 each. The amount of share capital decrease was distributed to the Company's shareholders in cash.
On 24 October 2024, the share capital reduction was approved via court order. The Company's issued share capital was reduced to €10,503,085 divided in 1,250,367,229 ordinary shares of €0.0084 each.
| 31/12/2024 | 31/12/2023 | |
|---|---|---|
| € | € | |
| VAT | 6,461 | 1,167 |
| Shareholders' current accounts - credit balances (Note 19.2) | 3,526 | 2,035 |
| Accruals | 59,500 | 50,496 |
| Other creditors | 29,892 | 46,123 |
| 99,379 | 99,821 |
| 31/12/2024 | 31/12/2023 | |
|---|---|---|
| € | € | |
| Refundable taxes | 266,440 | 338,143 |
| Special contribution for defence | - | 26,503 |
| 266,440 | 364,646 |
| 31/12/2024 | 31/12/2023 | |
|---|---|---|
| € | € | |
| Corporation tax | 134,258 | - |
| - | - | |
| 134,258 | - |
The balances with related parties are as follows:
The Directors's fees were as follows:
| 01/01/2024- | 01/01/2023- | |
|---|---|---|
| 31/12/2024 | 31/12/2023 | |
| € | € | |
| Directors' fees | 24,000 | 24,000 |
| 24,000 | 24,000 | |
| 19.2 Shareholders' current accounts - credit balances (Note 17) | ||
| 31/12/2024 | 31/12/2023 | |
| € | € | |
| Shareholders' current accounts - credit balances | 3,526 | 2,035 |
| 3,526 | 2,035 |
The shareholders' current accounts are interest free, and have no specified repayment date.
During February 2025, the Company received coupon payments of €3,367,170.
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.